Since March 2015 Ilaria has been working in Dr. Laura Parkkinen's research group as Post-doctoral fellow.
After graduating from University of Trieste (Trieste, Italy) in Neuroscience, Ilaria was enrolled in the Ph.D. program of Functional and Structural Genomics at the International School for Advanced Studies (SISSA, Trieste, Italy). The major goal of her Ph.D. project concerned the analysis of the expression of the cellular prion protein (PrPC) in the central nervous system (CNS) of mammals at different neurodevelopmental stages with the aim to understand its physiological role along neurodevelopment. In December 2012 Ilaria received the Doctor of Philosophy degree defending a thesis entitled “Insights in the Regional Distribution and Physiological Role of the Cellular Prion Protein in the Central Nervous System of Mammalian Organisms”.
In January 2013 Ilaria started her first post-doc in Prof. Piero Parchi’s Neuropathology Laboratory at the University of Bologna (Bologna, Italy). Here she was involved in the optimization and standardization of a recently developed analytical procedure called real-time quaking-induced conversion (RT-QuIC) which allows for the first time the detection of disease-associated prion protein in the cerebrospinal fluid (CSF) of patients affected by prion diseases as for instance Creutzfeldt-Jakob disease (CJD).
In March 2015 Ilaria was recruited as a postdoctoral fellow by Dr. Laura Parkkinen to work in a project funded by the Michael J Fox Foundation (MJFF) aiming to develop new early-stage biomarkers for Parkinson’s Disease (PD) based on the biology of alpha-synuclein.